RAISE: A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Confirm the Safety, Tolerability, and Efficacy of Zilucoplan in Subjects with Generalized Myasthenia Gravis

September 01, 2021
https://clinicaltrials.gov/ct2/show/NCT04115293
Myasthenia Gravis
Principal Investigator: Kavita M Grover, MD
Myasthenia Gravis, Autoimmune Disease, Musculoskeletal Disease
Accepting Participants
313-916-1364